GDF15 and prostate neoplasm: TRAMPMIC-/- mice had significantly larger prostate tumors and shorter survival than TRAMPMIC+/+ mice, but there was no significant difference in the incidence and rate of metastasis in the two mouse lines suggesting that different mechanisms mediate the effects of MIC-1/GDF-15 on local and metastatic PCa development.